Although the biological significance of these antigens remains unclear, it was recently reported that CEA inhibits anoikis by binding to TRAIL receptor DR-5 and preventing apoptotic signaling in tumor cells [57]. The gene discussed is CEACAM5; the disease is neoplasm.